Navigation Links
Biotech Survives Market Turbulence in November
Date:12/3/2007

he most promising biotech drugs will be intense.

"Among the glut of transactions during November was Glaxo's acquisition of privately-held Reliant Pharmaceuticals for $1.65 billion and Pfizer's acquisition of Coley Pharmaceuticals for $164 million. Reliant was planning $400 million initial public offering and its decision to be acquired provided a major premium for the company's investors.

"The environment for M&A is bullish right now... so much so that biotech's are planting 'for sale' signs on their lots," Burrill explained. "Following Biogen Idec, which put itself up for sale last month, Vancouver-based QLT said it was seeking potential buyers for some or all of its assets and MGI Pharma announced that it was looking at its options including a buyer."

Biotech IPOs

The uncertain capital markets weighed on biotech companies hoping to move off the IPO runway. In November only ARYx Therapeutics, which re-engineers commercially successful drugs to eliminate safety issues, priced a 5 million share offering at $10 -- significantly lower than its original $14 to $16 range.

Two other companies added themselves to the runway: Aegerion Pharmaceuticals, Inc. that is focused on development of small-molecule therapeutics to treat cardiovascular and metabolic disease; and ChemoCentryx, which is developing therapeutics targeting chemokine receptors to prevent autoimmune disorders and certain cancers.

Biotech Indices

"With one month to go the Burrill Biotech Select Index is up 16.6% year- to-date, well ahead of the Dow and Nasdaq. This is an excellent return considering the ongoing uncertainties in the general markets," said Burrill.

Major movers in the Biotech Select Index in November were Neurocrine Biosciences (up 41%) and Millennium Pharmaceuticals Inc. (up 25%). At one point shares of Millennium hit a new annual high amid a sharp rise in revenues for their cancer drug Velcade and upcoming Phase III trial data in multipl
'/>"/>

SOURCE Burrill & Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 Becht Engineering Co., ... it has acquired The CECON Group, Inc., located ... were not announced. , Becht Engineering (http://www.becht.com ... sector including oil and gas production, refining, petrochemical, ... nuclear power sectors. The company has twelve offices ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/s3s3t8/personalized ... new report "Personalized Medicine - Scientific and ... The aim of personalized medicine or ... to the right patient and, in some cases, ... patient according to his/her genotype. This report describes ...
(Date:3/3/2015)... 2015  Johnson & Johnson Innovation LLC today announced ... (JLABS @SSF), a 30,000-square foot incubator located ... Francisco, Calif. The Johnson & Johnson Innovation, ... from across the healthcare spectrum including biotech, pharmaceutical, medical ... first resident startups have been selected, including the winners ...
(Date:3/3/2015)... , March 3, 2015  Synthetic Biologics, Inc. (NYSE ... and diseases, with a focus on protecting the microbiome, announced ... scheduled to present at the 27th Annual ROTH Conference being ... Laguna Niguel in Dana Point, CA. ... March 10, 2015 at 1:00 p.m. (Pacific Time). ...
Breaking Biology Technology:Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5Synthetic Biologics to Present at the 27th Annual ROTH Conference 2
... Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) announced today that ... Second Annual Hidden Gems Conference on October,13, 2008 at ... the,Waldorf=Astoria Hotel in New York City. Robert E. Hoffman, ... to provide an,overview of the company, including its clinical ...
... 7 Nektar,Therapeutics (Nasdaq: NKTR ) President and ... upcoming Natixis Bleichroeder Second Annual Hidden Gems,Conference in New ... at 2:30 p.m. ET., The presentation will be ... Relations, Events Calendar section of the Nektar website:, http://www.nektar.com ...
... 7 MKS Instruments, Inc.,(Nasdaq: MKSI ), ... and improve productivity, today announced that it will ... opening on Wednesday,October 22, 2008. A conference call ... 8:30 a.m. (Eastern Time). The call will be ...
Cached Biology Technology:Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference 2Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference 3
(Date:2/18/2015)... Feb. 18, 2015  Cepheid (NASDAQ: CPHD ) ... following conferences, and invited investors to participate via webcast. ... MA Tuesday, March 3, 2015 at 11.20 a.m. ... Orlando, FL Wednesday, March 4, 2015 at ... access the live webcasts for these events, please visit Cepheid,s ...
(Date:2/12/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED METHOD AND SYSTEM TO IMPROVE ... further establishes NXT-ID,s position in the emerging "Internet of ... ability for multiple devices to collaborate with one another ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... researchers from the British Antarctic Survey have collected individuals from ... and subjected them to increasing levels of water temperature to ... conditions that they are likely to experience in the future. ... living really close to their upper temperature range, and that ...
... A University of Wisconsin-Madison biomedical engineer and colleagues have developed ... could spare some women with increased breast cancer risk the ... a questionable lump or lesion. The universal technology will ... malignant or benign. The American Cancer Society recommends ...
... an effort to increase understanding of the medical device ... of product development more effectively, researchers at Stanford University ... device development process. Published in the June ... , the model was constructed based on best-practice analysis ...
Cached Biology News:New MRI technique could mean fewer breast biopsies in high-risk women 2Stanford researchers publish comprehensive model for medical device development 2Stanford researchers publish comprehensive model for medical device development 3